The Association for Professionals in Infection Control and Epidemiology (APIC) recently released its Guide to Hand Hygiene Programs for Infection Prevention, which focuses on topics such as regulatory oversight and reporting, hand hygiene products, hand hygiene monitoring and program implementation and strategy. GOJO, the inventors of PURELL® Advanced Hand Sanitizer, served as the sponsor of the guide.
The guide was developed based on input and expertise from a broad array of industry experts from both practice and research settings. The easy-to-use guide is designed for infection prevention professionals as well as non-infection prevention healthcare professionals. It is available for download on the APIC website.
“Hand hygiene is one of the most important measures we can take to prevent healthcare-associated infections (HAIs),” says David Mackay, GOJO vice president sales and marketing healthcare. “As an organization, we are committed to increasing hand hygiene compliance to decrease the occurrence of HAIs. GOJO is happy to provide support to APIC and its members.”
GOJO Industries is the inventor of PURELL® Advanced Hand Sanitizer and the leading global producer and marketer of skin health and hygiene solutions for away-from-home settings. The broad GOJO product portfolio includes hand cleaning, handwashing, hand sanitizing and skin care formulas under the GOJO®, PURELL® and PROVON® brand names. GOJO formulations use the latest advances in the science of skin care and sustainability. GOJO is known for state-of-the-art dispensing technology, engineered with attention to design, sustainability and functionality. GOJO programs promote healthy behaviors for hand hygiene, skin care and compliance in critical environments. GOJO is a privately held corporation headquartered in Akron, Ohio, with operations in the United Kingdom, France, Australia, Japan, Mexico, Canada and Brazil.
Source: GOJO Industries
Enhancing Poliovirus Surveillance: Key Insights for Infection Prevention Personnel
April 4th 2024The fight against poliovirus continues with renewed urgency as recent surveillance data reveals both progress and persistent challenges. In a critical update, infection prevention personnel are presented with key insights into the ongoing battle against this scourge.